Inventor · disambiguated record
Chengzhi Yu
Also filed as: YU CHENGZHI
7 granted patents·4 pending applications·7 citations·filing 2013–2024
75Inventor score
Top patents by PatentIndex Score
11 records- 0188US11993604B2Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitorsSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2022·Granted May 28, 2024·2 cites·32 claims
- 0283US11319323B2Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitorsSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2018·Granted May 3, 2022·3 cites·19 claims
- 0376US11091485B2Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine compound as protein kinase inhibitorSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2018·Granted Aug 17, 2021·2 cites·18 claims
- 0457US12499794B2Media data encryption, and media data playbackUNILUMIN GROUP CO LTD·Filed 2024·Granted Dec 16, 2025·0 cites·12 claims
- 0556US9499539B2Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathwayNANTBIOSCIENCE INC·Filed 2013·Granted Nov 22, 2016·0 cites·1 claims
- 0652US2023312583A11h-imidazo [4,5-h] quinazoline compound as novel selective flt3 inhibitorsSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2021·Application pending·0 cites
- 0752US2023122967A1Novel compounds as inhibitors of pcsk9SHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2021·Application pending·0 cites
- 0849US10183013B2Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathwayNANTBIOSCIENCE INC·Filed 2016·Granted Jan 22, 2019·0 cites·13 claims
- 0939US2020165225A1Bace1 inhibitors for treatment of alzheimer's diseaseNANTBIO INC·Filed 2018·Application pending·0 cites
- 1038US12428423B21H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitorSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2018·Granted Sep 30, 2025·0 cites·18 claims
- 1136US2018170942A1Polycyclic derivatives targeting ral gtpases and their therapeutical applicationsNANTBIO INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chengzhi Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →